Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Convalescent plasma for patients with severe COVID-19: a matched cohort study

Ralph Rogers, Fadi Shehadeh, Evangelia Mylona, Josiah Rich, Marguerite Neill, Francine Touzard-Romo, Sara Geffert, Jerome Larkin, Jeffrey A. Bailey, Shaolei Lu, Joseph Sweeney, Eleftherios Mylonakis
doi: https://doi.org/10.1101/2020.08.18.20177402
Ralph Rogers
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ralph_rogers@brown.edu
Fadi Shehadeh
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evangelia Mylona
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josiah Rich
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marguerite Neill
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francine Touzard-Romo
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Geffert
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerome Larkin
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey A. Bailey
2Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaolei Lu
2Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Sweeney
2Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleftherios Mylonakis
1Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The efficacy of convalescent plasma (CP) for the treatment of COVID-19 remains unclear.

Methods A matched cohort analysis of hospitalized patients with severe COVID-19. The impact of CP treatment on all cause in-hospital mortality was evaluated using univariate and multivariate Cox proportional-hazards models, and the impact of CP treatment on the time to hospital discharge was assessed using a stratified log-rank analysis.

Results 64 patients who received CP a median of 7 days after symptom onset were compared to a matched control group of 177 patients. Overall in-hospital mortality was 14.9%. There was no significant difference in the risk of in-hospital mortality between the two groups (adjusted hazard ratio [aHR] 0.93, 95% confidence interval [CI] 0.39 – 2.20). There was also no significant difference in the overall rate of hospital discharge (rate ratio [RR] 1.28, 95% CI 0.91 – 1.81), but a subgroup analysis of patients 65-years-old or greater who received CP demonstrated a significantly increased hospital discharge rate among these patients (RR 1.86, 95% CI 1.03 – 3.36). There was a greater than expected frequency of transfusion reactions in the CP group (2.8% reaction rate observed per unit transfused).

Conclusions The use of CP in this study was a safe treatment for COVID-19. There was no overall significant reduction of in-hospital mortality or increased rate of hospital discharge associated with the use of CP in this study, although there was a signal for improved outcomes among the elderly. Further adequately powered randomized studies should target this subgroup when assessing the efficacy CP treatment.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for this study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This matched cohort study was an electronic chart review approved by the Institutional Review Board of Rhode Island Hospital.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data underlying this article are available in the article.

  • Abbreviations

    AI
    antibody index
    COVID-19
    coronavirus disease 2019
    CI
    confidence interval
    CP
    convalescent plasma
    HFNC
    high-flow nasal cannula
    HR
    hazard ratio
    ICU
    intensive care unit
    IQR
    interquartile range
    NIPPV
    non-invasive positive pressure ventilation
    RR
    rate ratio
    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    SD
    standard deviation
    TACO
    transfusion-associated circulatory overload
    TRALI
    transfusion-related acute lung injury
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted August 21, 2020.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Convalescent plasma for patients with severe COVID-19: a matched cohort study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Convalescent plasma for patients with severe COVID-19: a matched cohort study
    Ralph Rogers, Fadi Shehadeh, Evangelia Mylona, Josiah Rich, Marguerite Neill, Francine Touzard-Romo, Sara Geffert, Jerome Larkin, Jeffrey A. Bailey, Shaolei Lu, Joseph Sweeney, Eleftherios Mylonakis
    medRxiv 2020.08.18.20177402; doi: https://doi.org/10.1101/2020.08.18.20177402
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Convalescent plasma for patients with severe COVID-19: a matched cohort study
    Ralph Rogers, Fadi Shehadeh, Evangelia Mylona, Josiah Rich, Marguerite Neill, Francine Touzard-Romo, Sara Geffert, Jerome Larkin, Jeffrey A. Bailey, Shaolei Lu, Joseph Sweeney, Eleftherios Mylonakis
    medRxiv 2020.08.18.20177402; doi: https://doi.org/10.1101/2020.08.18.20177402

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (166)
    • Anesthesia (49)
    • Cardiovascular Medicine (447)
    • Dentistry and Oral Medicine (80)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
    • Epidemiology (5199)
    • Forensic Medicine (3)
    • Gastroenterology (193)
    • Genetic and Genomic Medicine (746)
    • Geriatric Medicine (76)
    • Health Economics (211)
    • Health Informatics (689)
    • Health Policy (350)
    • Health Systems and Quality Improvement (221)
    • Hematology (98)
    • HIV/AIDS (161)
    • Infectious Diseases (except HIV/AIDS) (5793)
    • Intensive Care and Critical Care Medicine (355)
    • Medical Education (101)
    • Medical Ethics (25)
    • Nephrology (80)
    • Neurology (754)
    • Nursing (43)
    • Nutrition (129)
    • Obstetrics and Gynecology (141)
    • Occupational and Environmental Health (230)
    • Oncology (473)
    • Ophthalmology (149)
    • Orthopedics (37)
    • Otolaryngology (93)
    • Pain Medicine (39)
    • Palliative Medicine (19)
    • Pathology (138)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (135)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (851)
    • Public and Global Health (1985)
    • Radiology and Imaging (342)
    • Rehabilitation Medicine and Physical Therapy (154)
    • Respiratory Medicine (282)
    • Rheumatology (93)
    • Sexual and Reproductive Health (72)
    • Sports Medicine (74)
    • Surgery (107)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)